|
2014-10-14 |
2014-10-09 |
V
Vente
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Dirigeant
|
370
-0.4%
64,07
23 704 USD
|
370
-0.4%
|
64,07
|
23 704 USD
|
|
|
2014-10-07 |
2014-10-06 |
V
Vente
|
OConnell Christopher J
EVP & GroupPres Restora Therap
Dirigeant
|
15 388
-12.1%
64,98
999 929 USD
|
15 388
-12.1%
|
64,98
|
999 929 USD
|
|
|
2014-10-14 |
2014-10-03 |
V
Vente
|
COYLE MICHAEL J
EVP & Group Pres, Cardiac&Vasc
Dirigeant
|
571
-0.7%
65,03
37 132 USD
|
571
-0.7%
|
65,03
|
37 132 USD
|
|
|
2014-08-27 |
2014-08-26 |
V
Vente
|
OConnell Christopher J
EVP & GroupPres Restora Therap
Dirigeant
|
28 000
-17.9%
63,57
1 779 882 USD
|
28 000
-17.9%
|
63,57
|
1 779 882 USD
|
|
|
2014-04-11 |
2014-04-09 |
V
Vente
|
Kuntz Richard
SrVP & Chief Scien, Clin, Reg
Dirigeant
|
2 512
-2.3%
60,98
153 182 USD
|
2 512
-2.3%
|
60,98
|
153 182 USD
|
|
|
2014-04-03 |
2014-04-01 |
V
Vente
|
Ellis Gary Lee
SrVP & Chief Financial Officer
Dirigeant
|
4 246
-2.4%
61,48
261 034 USD
|
4 246
-2.4%
|
61,48
|
261 034 USD
|
|
|
2014-03-11 |
2014-03-10 |
V
Vente
|
AYOTTE NEIL P
VP Interim Gen Counsel CorpSec
Dirigeant
|
1 845
-14.6%
59,64
110 041 USD
|
1 845
-14.6%
|
59,64
|
110 041 USD
|
|
|
2014-03-03 |
2014-02-28 |
V
Vente
|
AYOTTE NEIL P
VP Interim Gen Counsel CorpSec
Dirigeant
|
116
-1.1%
59,54
6 907 USD
|
116
-1.1%
|
59,54
|
6 907 USD
|
|
|
2013-08-28 |
2013-08-26 |
V
Vente
|
Szyman Catherine M
SrVP & Pres Diabetes
Dirigeant
|
56 998
-72.9%
52,60
2 998 334 USD
|
56 998
-72.9%
|
52,60
|
2 998 334 USD
|
|
|
2013-08-23 |
2013-08-22 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
32 332
-35.3%
53,19
1 719 768 USD
|
32 332
-35.3%
|
53,19
|
1 719 768 USD
|
|
|
2013-08-22 |
2013-08-21 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
36 256
-28.4%
52,82
1 915 093 USD
|
36 256
-28.4%
|
52,82
|
1 915 093 USD
|
|
|
2013-08-22 |
2013-08-21 |
V
Vente
|
JACKSON SHIRLEY A
Administrateur non-exécutif
|
8 033
-24.4%
52,84
424 444 USD
|
8 033
-24.4%
|
52,84
|
424 444 USD
|
|
|
2013-07-15 |
2013-07-11 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
69 889
-42.9%
53,72
3 754 507 USD
|
69 889
-42.9%
|
53,72
|
3 754 507 USD
|
|
|
2013-07-11 |
2013-07-10 |
V
Vente
|
OConnell Christopher J
EVP & GroupPres Restora Therap
Dirigeant
|
29 243
-20.0%
52,89
1 546 738 USD
|
29 243
-20.0%
|
52,89
|
1 546 738 USD
|
|
|
2013-07-02 |
2013-07-01 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
20 579
-18.4%
52,10
1 072 232 USD
|
20 579
-18.4%
|
52,10
|
1 072 232 USD
|
|
|
2013-06-20 |
2013-06-19 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
2 789
-1.4%
52,08
145 249 USD
|
2 789
-1.4%
|
52,08
|
145 249 USD
|
|
|
2013-06-20 |
2013-06-19 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
12 304
-6.0%
52,77
649 281 USD
|
12 304
-6.0%
|
52,77
|
649 281 USD
|
|
|
2013-06-20 |
2013-06-19 |
V
Vente
|
Dallas H James
SrVP Quality, Operations, IT
Dirigeant
|
200
-0.1%
52,08
10 416 USD
|
200
-0.1%
|
52,08
|
10 416 USD
|
|
|
2013-05-22 |
2013-05-22 |
A
Achat
|
ANDERSON RICHARD H
Administrateur non-exécutif
|
680
+16.5%
52,32
35 575 USD
|
680
+16.5%
|
52,32
|
35 575 USD
|
|
|
2013-05-22 |
2013-05-22 |
A
Achat
|
ANDERSON RICHARD H
Administrateur non-exécutif
|
4 120
+inf%
52,32
215 558 USD
|
4 120
+inf%
|
52,32
|
215 558 USD
|
|
|
2013-06-27 |
2013-05-10 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
10 645
-32.7%
48,93
520 869 USD
|
10 645
-32.7%
|
48,93
|
520 869 USD
|
|
|
2013-06-27 |
2013-05-10 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
10 685
-32.9%
48,93
522 827 USD
|
10 685
-32.9%
|
48,93
|
522 827 USD
|
|
|
2013-06-27 |
2013-05-10 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
10 645
-32.7%
48,93
520 869 USD
|
10 645
-32.7%
|
48,93
|
520 869 USD
|
|
|
2012-06-19 |
2012-06-18 |
A
Achat
|
ANDERSON RICHARD H
Administrateur non-exécutif
|
4 400
+18.6%
37,94
166 932 USD
|
4 400
+18.6%
|
37,94
|
166 932 USD
|
|
|
2012-06-19 |
2012-06-18 |
A
Achat
|
ANDERSON RICHARD H
Administrateur non-exécutif
|
800
+3.5%
37,94
30 352 USD
|
800
+3.5%
|
37,94
|
30 352 USD
|
|
|
2013-06-27 |
2011-12-30 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
745
-2.2%
38,52
28 697 USD
|
745
-2.2%
|
38,52
|
28 697 USD
|
|
|
2013-06-27 |
2011-12-30 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
5
-0.0%
38,26
191 USD
|
5
-0.0%
|
38,26
|
191 USD
|
|
|
2013-06-27 |
2011-12-30 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
770
-2.3%
38,50
29 645 USD
|
770
-2.3%
|
38,50
|
29 645 USD
|
|
|
2013-06-27 |
2011-12-30 |
V
Vente
|
SCHULER JACK W
Administrateur non-exécutif
|
735
-2.2%
38,50
28 298 USD
|
735
-2.2%
|
38,50
|
28 298 USD
|
|
|
2011-09-02 |
2011-09-01 |
A
Achat
|
Powell Kendall J
Administrateur non-exécutif
|
3 000
+inf%
35,20
105 600 USD
|
3 000
+inf%
|
35,20
|
105 600 USD
|
|
|
2011-08-04 |
2011-08-04 |
VP
Vente planifiée
|
OConnell Christopher J
EVP & GroupPres Restora Therap
Dirigeant
|
4 000
-3.9%
33,98
135 920 USD
|
4 000
-3.9%
|
33,98
|
135 920 USD
|
|
|
2011-05-26 |
2011-05-25 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
25 000
+5.1%
40,70
1 017 610 USD
|
25 000
+5.1%
|
40,70
|
1 017 610 USD
|
|
|
2010-12-23 |
2010-12-22 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
100 000
+25.7%
37,06
3 706 040 USD
|
100 000
+25.7%
|
37,06
|
3 706 040 USD
|
|
|
2010-07-08 |
2010-07-06 |
A
Achat
|
Lenehan James T
Administrateur non-exécutif
|
500
+2.6%
36,28
18 140 USD
|
500
+2.6%
|
36,28
|
18 140 USD
|
|
|
2010-07-08 |
2010-07-06 |
A
Achat
|
Lenehan James T
Administrateur non-exécutif
|
2 500
+15.0%
36,27
90 675 USD
|
2 500
+15.0%
|
36,27
|
90 675 USD
|
|
|
2010-06-29 |
2010-06-25 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
300
+1.0%
36,93
11 078 USD
|
300
+1.0%
|
36,93
|
11 078 USD
|
|
|
2010-06-29 |
2010-06-25 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
29 700
+inf%
36,93
1 096 821 USD
|
29 700
+inf%
|
36,93
|
1 096 821 USD
|
|
|
2010-04-13 |
2010-04-09 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
1 454
-3.3%
45,33
65 911 USD
|
1 454
-3.3%
|
45,33
|
65 911 USD
|
|
|
2010-03-30 |
2010-03-26 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
100
-0.2%
44,55
4 455 USD
|
100
-0.2%
|
44,55
|
4 455 USD
|
|
|
2010-03-30 |
2010-03-26 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
323
-0.7%
44,55
14 390 USD
|
323
-0.7%
|
44,55
|
14 390 USD
|
|
|
2010-03-30 |
2010-03-26 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
900
-2.0%
44,52
40 068 USD
|
900
-2.0%
|
44,52
|
40 068 USD
|
|
|
2010-03-30 |
2010-03-26 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
4 809
-9.7%
44,51
214 051 USD
|
4 809
-9.7%
|
44,51
|
214 051 USD
|
|
|
2010-03-30 |
2010-03-26 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
3 643
-6.8%
45,00
163 935 USD
|
3 643
-6.8%
|
45,00
|
163 935 USD
|
|
|
2010-01-11 |
2010-01-11 |
V
Vente
|
Mackin James P
SVP & Pres CRDM
Dirigeant
|
100
-0.1%
45,89
4 589 USD
|
100
-0.1%
|
45,89
|
4 589 USD
|
|
|
2010-01-11 |
2010-01-11 |
V
Vente
|
Mackin James P
SVP & Pres CRDM
Dirigeant
|
4 096
-4.2%
45,89
187 965 USD
|
4 096
-4.2%
|
45,89
|
187 965 USD
|
|
|
2010-01-11 |
2010-01-07 |
V
Vente
|
Mackin James P
SVP & Pres CRDM
Dirigeant
|
109
-0.1%
45,60
4 970 USD
|
109
-0.1%
|
45,60
|
4 970 USD
|
|
|
2010-01-11 |
2010-01-07 |
V
Vente
|
Mackin James P
SVP & Pres CRDM
Dirigeant
|
4 388
-4.3%
45,70
200 532 USD
|
4 388
-4.3%
|
45,70
|
200 532 USD
|
|
|
2009-10-20 |
2009-10-16 |
V
Vente
|
Ellis Gary Lee
SrVP & Chief Financial Officer
Dirigeant
|
19 623
-12.8%
37,01
726 165 USD
|
19 623
-12.8%
|
37,01
|
726 165 USD
|
|
|
2009-10-06 |
2009-10-05 |
V
Vente
|
OConnell Christopher J
EVP & GroupPres S&B N D ST
Dirigeant
|
579
-0.7%
36,31
21 023 USD
|
579
-0.7%
|
36,31
|
21 023 USD
|
|
|
2009-10-06 |
2009-10-05 |
V
Vente
|
OConnell Christopher J
EVP & GroupPres S&B N D ST
Dirigeant
|
8 478
-9.8%
36,30
307 751 USD
|
8 478
-9.8%
|
36,30
|
307 751 USD
|
|
|
2009-05-27 |
2009-05-22 |
V
Vente
|
Szyman Catherine M
SrVP Strategy Innovation
Dirigeant
|
1 239
-3.4%
32,47
40 230 USD
|
1 239
-3.4%
|
32,47
|
40 230 USD
|
|
|
2008-10-14 |
2008-10-10 |
A
Achat
|
ROSSO JEAN PIERRE
Administrateur non-exécutif
|
1 000
+6.0%
40,41
40 409 USD
|
1 000
+6.0%
|
40,41
|
40 409 USD
|
|
|
2008-09-29 |
2008-09-25 |
V
Vente
|
OConnell Christopher J
SVP & Pres Diabetes
Dirigeant
|
300
-0.5%
52,85
15 856 USD
|
300
-0.5%
|
52,85
|
15 856 USD
|
|
|
2008-09-29 |
2008-09-25 |
V
Vente
|
OConnell Christopher J
SVP & Pres Diabetes
Dirigeant
|
848
-1.3%
52,85
44 813 USD
|
848
-1.3%
|
52,85
|
44 813 USD
|
|
|
2008-07-15 |
2008-07-11 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
2 010
-18.5%
52,50
105 525 USD
|
2 010
-18.5%
|
52,50
|
105 525 USD
|
|
|
2008-07-15 |
2008-07-11 |
V
Vente
|
LaNeve Stephen
SVP & Pres Spinal & Biologics
Dirigeant
|
2 010
-15.6%
52,25
105 023 USD
|
2 010
-15.6%
|
52,25
|
105 023 USD
|
|
|
2008-07-14 |
2008-07-10 |
V
Vente
|
Szyman Catherine M
SVP Strategy & Innovation
Dirigeant
|
17 822
-59.3%
52,66
938 487 USD
|
17 822
-59.3%
|
52,66
|
938 487 USD
|
|
|
2008-02-25 |
2008-02-22 |
A
Achat
|
Dallas H James
SrVP & Chief Information Offcr
Dirigeant
|
387
+0.6%
48,18
18 646 USD
|
387
+0.6%
|
48,18
|
18 646 USD
|
|
|
2008-02-25 |
2008-02-22 |
A
Achat
|
Dallas H James
SrVP & Chief Information Offcr
Dirigeant
|
14 610
+28.0%
48,18
703 895 USD
|
14 610
+28.0%
|
48,18
|
703 895 USD
|
|
|
2008-02-25 |
2008-02-22 |
A
Achat
|
Dallas H James
SrVP & Chief Information Offcr
Dirigeant
|
600
+1.2%
48,15
28 890 USD
|
600
+1.2%
|
48,15
|
28 890 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
3 700
+40.2%
49,40
182 780 USD
|
3 700
+40.2%
|
49,40
|
182 780 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
2 000
+0.5%
49,49
98 980 USD
|
2 000
+0.5%
|
49,49
|
98 980 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
7 500
+2.0%
49,45
370 875 USD
|
7 500
+2.0%
|
49,45
|
370 875 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
5 400
+1.5%
49,44
266 976 USD
|
5 400
+1.5%
|
49,44
|
266 976 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
6 100
+1.7%
49,43
301 523 USD
|
6 100
+1.7%
|
49,43
|
301 523 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
11 600
+3.3%
49,40
573 040 USD
|
11 600
+3.3%
|
49,40
|
573 040 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
5 100
+1.5%
49,39
251 889 USD
|
5 100
+1.5%
|
49,39
|
251 889 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
11 300
+3.4%
49,38
557 994 USD
|
11 300
+3.4%
|
49,38
|
557 994 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
700
+0.2%
49,37
34 559 USD
|
700
+0.2%
|
49,37
|
34 559 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
6 200
+1.9%
49,35
305 970 USD
|
6 200
+1.9%
|
49,35
|
305 970 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
6 000
+1.9%
49,34
296 040 USD
|
6 000
+1.9%
|
49,34
|
296 040 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
9 000
+2.9%
49,33
443 970 USD
|
9 000
+2.9%
|
49,33
|
443 970 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
600
+0.2%
49,32
29 592 USD
|
600
+0.2%
|
49,32
|
29 592 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
2 500
+0.8%
49,31
123 275 USD
|
2 500
+0.8%
|
49,31
|
123 275 USD
|
|
|
2008-02-22 |
2008-02-21 |
A
Achat
|
SCHULER JACK W
Administrateur non-exécutif
|
9 000
+3.0%
49,30
443 700 USD
|
9 000
+3.0%
|
49,30
|
443 700 USD
|
|
